Vandria AG
Pharmaceuticals · Epalinges, Vaud
Vandria AG is a Swiss pharmaceuticals company based in Epalinges, Canton of Vaud, listed in the Swiss commercial register since 2021 (UID CHE-150.318.261).
Board members & signatories
- Eckstein Jens — Mitglied des Verwaltungsrates
- Schubert Ryan — Mitglied des Verwaltungsrates
- Dugi Klaus — Direktor
Registered purpose
la société a pour but la recherche, le développement, la fabrication et la commercialisation de produits pharmaceutiques dans le domaine des sciences de la vie, notamment le développement des produits permettant de lutter contre les maladies liées aux dysfonctionnements mitochondriaux, notamment les maladies liées au vieillissement. La société peut: - exercer toute activité financière, commerciale…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Vandria does
OFFERING
Vandria AG develops small molecules aimed at improving mitochondrial function and reducing chronic inflammation to treat age-related diseases. Their lead clinical asset, VNA-318, is an orally available small molecule that has completed Phase I clinical studies, demonstrating safety and tolerability.
Unlock the full analysis →Similar companies
- cellvie AG — Biotechnology · Zürich
- CanVirex AG — Pharmaceuticals · Basel
- Vaderis Therapeutics AG — Pharmaceuticals · Basel
- Roivant Sciences GmbH — Biotechnology · Basel
- Adagene AG — Pharmaceuticals · Basel
- Travere Therapeutics Switzerland GmbH — Biotechnology · Rapperswil SG
Find every pharmaceuticals company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned pharmaceuticals companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime